Skip to main content
Erschienen in: Endocrine 2/2014

01.11.2014 | Editorial

Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect

verfasst von: Andrea Giustina, Gherardo Mazziotti

Erschienen in: Endocrine | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Excerpt

Hattori et al. [1] in this issue of Endocrine report on an interesting experimental model of dioxin-induced fetal growth retardation. This study found that oral administration of dioxin to pregnant rats reduced both the pituitary expression and serum levels of growth hormone (GH) in perinatal pups [1]. Concomitantly, dioxin decreased serum concentration of corticosterone in the studied model. Administration of physiological doses of corticosterone to dioxin-exposed mothers restored or tended to restore the dioxin-induced reduction of both GH expression and fetal body weight [1]. Taken together, these observations suggest that dioxin-induced fetal growth disorders are due, at least in part, to impaired GH expression and secretion in the presence of low circulating glucocorticoids [1]. …
Literatur
1.
Zurück zum Zitat Y. Hattori, T. Takeda, M. Fuji, J. Taura, Y. Ishi, H. Yamada, Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid. Endocrine (2014). doi:10.1007/s12020-014-0257-3 PubMed Y. Hattori, T. Takeda, M. Fuji, J. Taura, Y. Ishi, H. Yamada, Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid. Endocrine (2014). doi:10.​1007/​s12020-014-0257-3 PubMed
2.
Zurück zum Zitat A. Giustina, J.D. Veldhuis, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717–797 (1998)PubMed A. Giustina, J.D. Veldhuis, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717–797 (1998)PubMed
3.
Zurück zum Zitat X. Han, Y. Zhu, Y. Zhao, C. Chen, Ghrelin reduces voltage-gated calcium currents in GH3 cells via cyclic GMP pathways. Endocrine 40, 228–236 (2011)PubMedCrossRef X. Han, Y. Zhu, Y. Zhao, C. Chen, Ghrelin reduces voltage-gated calcium currents in GH3 cells via cyclic GMP pathways. Endocrine 40, 228–236 (2011)PubMedCrossRef
4.
Zurück zum Zitat A. Giustina, W.B. Wehrenberg, Influence of thyroid hormones on the regulation of growth hormone secretion. Eur. J. Endocrinol. 133, 646–653 (1995)PubMedCrossRef A. Giustina, W.B. Wehrenberg, Influence of thyroid hormones on the regulation of growth hormone secretion. Eur. J. Endocrinol. 133, 646–653 (1995)PubMedCrossRef
5.
Zurück zum Zitat A. Giustina, M. Licini, A.R. Bussi, A. Girelli, G. Pizzocolo, M. Schettino, Effects of sex and age on the growth hormone response to galanin in healthy human subjects. J. Clin. Endocrinol. Metab. 76, 1369–1372 (1993)PubMed A. Giustina, M. Licini, A.R. Bussi, A. Girelli, G. Pizzocolo, M. Schettino, Effects of sex and age on the growth hormone response to galanin in healthy human subjects. J. Clin. Endocrinol. Metab. 76, 1369–1372 (1993)PubMed
6.
Zurück zum Zitat W.B. Wehrenberg, A. Giustina, Basic counterpoint: mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr. Rev. 13, 299–308 (1992)PubMed W.B. Wehrenberg, A. Giustina, Basic counterpoint: mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr. Rev. 13, 299–308 (1992)PubMed
7.
Zurück zum Zitat P. Kamenický, G. Mazziotti, M. Lombès, A. Giustina, P. Chanson, Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr. Rev. 35, 234–281 (2014)PubMedCrossRef P. Kamenický, G. Mazziotti, M. Lombès, A. Giustina, P. Chanson, Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr. Rev. 35, 234–281 (2014)PubMedCrossRef
8.
Zurück zum Zitat A. Giustina, R. Lorusso, V. Borghetti, G. Bugari, V. Misitano, O. Alfieri, Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. Am. Heart J. 131, 620–622 (1996)PubMedCrossRef A. Giustina, R. Lorusso, V. Borghetti, G. Bugari, V. Misitano, O. Alfieri, Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. Am. Heart J. 131, 620–622 (1996)PubMedCrossRef
9.
Zurück zum Zitat A. Giustina, S. Bossoni, A.R. Bussi, A. Pozzi, W.B. Wehrenberg, Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing’s disease. Endocr. Res. 19, 47–56 (1993)PubMedCrossRef A. Giustina, S. Bossoni, A.R. Bussi, A. Pozzi, W.B. Wehrenberg, Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing’s disease. Endocr. Res. 19, 47–56 (1993)PubMedCrossRef
10.
Zurück zum Zitat A. Giustina, W.B. Wehrenberg, The role of glucocorticoids in the regulation of growth hormone secretion: mechanisms and clinical significance. Trends Endocrinol. Metab. 8, 306–311 (1992)CrossRef A. Giustina, W.B. Wehrenberg, The role of glucocorticoids in the regulation of growth hormone secretion: mechanisms and clinical significance. Trends Endocrinol. Metab. 8, 306–311 (1992)CrossRef
11.
Zurück zum Zitat G. Mazziotti, A. Giustina, Glucocorticoids and the regulation of growth hormone secretion. Nat. Rev. Endocrinol. 9, 265–276 (2013)PubMedCrossRef G. Mazziotti, A. Giustina, Glucocorticoids and the regulation of growth hormone secretion. Nat. Rev. Endocrinol. 9, 265–276 (2013)PubMedCrossRef
12.
Zurück zum Zitat H. Vakili, P.A. Cattini, The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells. Mol. Cell. Endocrinol. 363, 1–9 (2012)PubMedCrossRef H. Vakili, P.A. Cattini, The hidden but positive role for glucocorticoids in the regulation of growth hormone-producing cells. Mol. Cell. Endocrinol. 363, 1–9 (2012)PubMedCrossRef
13.
Zurück zum Zitat C.E. Dean, B. Morpurgo, T.E. Porter, Induction of somatotroph differentiation in vivo by corticosterone administration during chicken embryonic development. Endocrine 11, 151–156 (1999)PubMedCrossRef C.E. Dean, B. Morpurgo, T.E. Porter, Induction of somatotroph differentiation in vivo by corticosterone administration during chicken embryonic development. Endocrine 11, 151–156 (1999)PubMedCrossRef
14.
Zurück zum Zitat M. Tamaki, M. Sato, S. Matsubara, Y. Wada, J. Takahara, Dexamethasone increases growth hormone (GH)-releasing hormone (GHR) receptor mRNA levels in culture rat anterior pituitary cells. Neuroendocrinology 8, 475–480 (1996)CrossRef M. Tamaki, M. Sato, S. Matsubara, Y. Wada, J. Takahara, Dexamethasone increases growth hormone (GH)-releasing hormone (GHR) receptor mRNA levels in culture rat anterior pituitary cells. Neuroendocrinology 8, 475–480 (1996)CrossRef
15.
Zurück zum Zitat H. Tamura, J. Kamegai, H. Sugihara, R.D. Kineman, L.A. Frohman, I. Wakabayashi, Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 12, 481–485 (2000)PubMedCrossRef H. Tamura, J. Kamegai, H. Sugihara, R.D. Kineman, L.A. Frohman, I. Wakabayashi, Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 12, 481–485 (2000)PubMedCrossRef
16.
Zurück zum Zitat T.L. Miller, K.E. Mayo, Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 138, 2458–2465 (1997)PubMed T.L. Miller, K.E. Mayo, Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 138, 2458–2465 (1997)PubMed
17.
Zurück zum Zitat W.B. Wehrenberg, A. Baird, N. Ling, Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Science 221, 556–558 (1983)PubMedCrossRef W.B. Wehrenberg, A. Baird, N. Ling, Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Science 221, 556–558 (1983)PubMedCrossRef
18.
Zurück zum Zitat D.M. Voltz, A.W. Piering, M. Magestro, A. Giustina, W.B. Wehrenberg, Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci. 56, 491–497 (1995)PubMedCrossRef D.M. Voltz, A.W. Piering, M. Magestro, A. Giustina, W.B. Wehrenberg, Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci. 56, 491–497 (1995)PubMedCrossRef
19.
Zurück zum Zitat A. Giustina, V. Misitano, D. Voltz, A. Piering, W.B. Wehrenberg, Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats. Endocr. Res. 21, 719–732 (1995)PubMed A. Giustina, V. Misitano, D. Voltz, A. Piering, W.B. Wehrenberg, Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats. Endocr. Res. 21, 719–732 (1995)PubMed
20.
Zurück zum Zitat A. Giustina, D.M. Voltz, J. Teik, W.B. Wehrenberg, Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat. Metabolism 44, 224–227 (1995)PubMedCrossRef A. Giustina, D.M. Voltz, J. Teik, W.B. Wehrenberg, Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat. Metabolism 44, 224–227 (1995)PubMedCrossRef
21.
Zurück zum Zitat W.B. Wehrenberg, P.J. Bergman, L. Stagg, J. Ndon, A. Giustina, Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology 127, 2705–2708 (1990)PubMedCrossRef W.B. Wehrenberg, P.J. Bergman, L. Stagg, J. Ndon, A. Giustina, Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology 127, 2705–2708 (1990)PubMedCrossRef
22.
Zurück zum Zitat G. Tulipano, D. Soldi, M. Bagnasco, M.D. Culler, J.E. Taylor, D. Cocchi, A. Giustina, Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 143, 1218–1224 (2002)PubMedCrossRef G. Tulipano, D. Soldi, M. Bagnasco, M.D. Culler, J.E. Taylor, D. Cocchi, A. Giustina, Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 143, 1218–1224 (2002)PubMedCrossRef
23.
Zurück zum Zitat A. Giustina, G. Romanelli, R. Candrina, G. Giustina, Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J. Clin. Endocrinol. Metab. 68, 120–124 (1989)PubMedCrossRef A. Giustina, G. Romanelli, R. Candrina, G. Giustina, Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J. Clin. Endocrinol. Metab. 68, 120–124 (1989)PubMedCrossRef
24.
Zurück zum Zitat S.K. McMahon, C.J. Pretorius, J.P. Ungerer, N.J. Salmon, L.S. Conwell, M.A. Pearen, J.A. Batch, Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J. Clin. Endocrinol. Metab. 95, 297–302 (2010)PubMedCrossRef S.K. McMahon, C.J. Pretorius, J.P. Ungerer, N.J. Salmon, L.S. Conwell, M.A. Pearen, J.A. Batch, Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J. Clin. Endocrinol. Metab. 95, 297–302 (2010)PubMedCrossRef
25.
Zurück zum Zitat R. McEachern, J. Drouin, L. Metherell, C. Huot, G. Van Vliet, C. Deal, Severe cortisol deficiency associated with reversible growth hormone deficiency in two infants: what is the link? J. Clin. Endocrinol. Metab. 96, 2670–2674 (2011)PubMedCrossRef R. McEachern, J. Drouin, L. Metherell, C. Huot, G. Van Vliet, C. Deal, Severe cortisol deficiency associated with reversible growth hormone deficiency in two infants: what is the link? J. Clin. Endocrinol. Metab. 96, 2670–2674 (2011)PubMedCrossRef
26.
Zurück zum Zitat A. Giustina, M. Doga, C. Bodini, A. Girelli, F. Legati, S. Bossoni, G. Romanelli, Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. Acta Endocrinol. 122, 206–210 (1990)PubMed A. Giustina, M. Doga, C. Bodini, A. Girelli, F. Legati, S. Bossoni, G. Romanelli, Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. Acta Endocrinol. 122, 206–210 (1990)PubMed
27.
Zurück zum Zitat A. Giustina, A. Girelli, M. Doga, C. Bodini, S. Bossoni, G. Romanelli, W.B. Wehrenberg, Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone releasing hormone stimulated growth hormone secretion in normal men. J. Clin. Endocrinol. Metab. 71, 580–584 (1990)PubMedCrossRef A. Giustina, A. Girelli, M. Doga, C. Bodini, S. Bossoni, G. Romanelli, W.B. Wehrenberg, Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone releasing hormone stimulated growth hormone secretion in normal men. J. Clin. Endocrinol. Metab. 71, 580–584 (1990)PubMedCrossRef
28.
Zurück zum Zitat W.B. Wehrenberg, S.D. Wiviott, D.M. Voltz, A. Giustina, Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement. Endocrinology 130, 1445–1450 (1992)PubMed W.B. Wehrenberg, S.D. Wiviott, D.M. Voltz, A. Giustina, Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement. Endocrinology 130, 1445–1450 (1992)PubMed
29.
Zurück zum Zitat A. Giustina, A. Girelli, D. Alberti, S. Bossoni, F. Buzi, M. Doga, M. Schettino, W.B. Wehrenberg, Effects of pyridostigmine on spontaneous and growth hormone- releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin. Endocrinol. 35, 91–98 (1991)CrossRef A. Giustina, A. Girelli, D. Alberti, S. Bossoni, F. Buzi, M. Doga, M. Schettino, W.B. Wehrenberg, Effects of pyridostigmine on spontaneous and growth hormone- releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin. Endocrinol. 35, 91–98 (1991)CrossRef
30.
Zurück zum Zitat A. Giustina, S. Bossoni, C. Bodini, A. Girelli, G.P. Balestrieri, G. Pizzocolo, W.B. Wehrenberg, Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy. J. Clin. Endocrinol. Metab. 74, 1301–1305 (1992)PubMed A. Giustina, S. Bossoni, C. Bodini, A. Girelli, G.P. Balestrieri, G. Pizzocolo, W.B. Wehrenberg, Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy. J. Clin. Endocrinol. Metab. 74, 1301–1305 (1992)PubMed
31.
Zurück zum Zitat M. Malerba, S. Bossoni, A. Radaeli, E. Mori, S. Bonadonna, A. Giustina, C. Tantucci, Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment. Chest 127, 515–521 (2005)PubMedCrossRef M. Malerba, S. Bossoni, A. Radaeli, E. Mori, S. Bonadonna, A. Giustina, C. Tantucci, Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment. Chest 127, 515–521 (2005)PubMedCrossRef
32.
Zurück zum Zitat M. Terzolo, S. Bossoni, A. Alí, M. Doga, G. Reimondo, G. Milani, P. Peretti, F. Manelli, A. Angeli, A. Giustina, Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. J. Clin. Endocrinol. Metab. 85, 1310–1315 (2000)PubMedCrossRef M. Terzolo, S. Bossoni, A. Alí, M. Doga, G. Reimondo, G. Milani, P. Peretti, F. Manelli, A. Angeli, A. Giustina, Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. J. Clin. Endocrinol. Metab. 85, 1310–1315 (2000)PubMedCrossRef
33.
Zurück zum Zitat G. Rachelefsky, Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Pediatrics 123, 353–366 (2009)PubMedCrossRef G. Rachelefsky, Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Pediatrics 123, 353–366 (2009)PubMedCrossRef
34.
Zurück zum Zitat G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58–69 (2012)PubMedCrossRef G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41, 58–69 (2012)PubMedCrossRef
35.
Zurück zum Zitat G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMedCrossRef G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMedCrossRef
36.
Zurück zum Zitat G. Mazziotti, T. Porcelli, A. Bianchi, V. Cimino, I. Patelli, C. Mejia, A. Fusco, A. Giampietro, L. De Marinis, A. Giustina, Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur. J. Endocrinol. 163, 15–20 (2010)PubMedCrossRef G. Mazziotti, T. Porcelli, A. Bianchi, V. Cimino, I. Patelli, C. Mejia, A. Fusco, A. Giampietro, L. De Marinis, A. Giustina, Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur. J. Endocrinol. 163, 15–20 (2010)PubMedCrossRef
37.
Zurück zum Zitat A. Giustina, A.R. Bussi, C. Jacobello, W.B. Wehrenberg, Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 80, 122–129 (1995)PubMed A. Giustina, A.R. Bussi, C. Jacobello, W.B. Wehrenberg, Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 80, 122–129 (1995)PubMed
38.
Zurück zum Zitat F.F. Horber, M.W. Haymond, Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J. Clin. Invest. 86, 265–272 (1990)PubMedCrossRefPubMedCentral F.F. Horber, M.W. Haymond, Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J. Clin. Invest. 86, 265–272 (1990)PubMedCrossRefPubMedCentral
39.
Zurück zum Zitat A. Giustina, E. Bresciani, S. Bossoni, L. Chiesa, V. Misitano, W.B. Wehrenberg, J.D. Veldhuis, Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. 79, 1266–1272 (1994)PubMed A. Giustina, E. Bresciani, S. Bossoni, L. Chiesa, V. Misitano, W.B. Wehrenberg, J.D. Veldhuis, Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. 79, 1266–1272 (1994)PubMed
Metadaten
Titel
Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect
verfasst von
Andrea Giustina
Gherardo Mazziotti
Publikationsdatum
01.11.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0278-y

Weitere Artikel der Ausgabe 2/2014

Endocrine 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.